Li-Yia Feng
Overview
Explore the profile of Li-Yia Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin C, Chiang W, Tung C, Hsieh J, Hsiao J, Huang W, et al.
Mol Med Rep
. 2014 Oct;
11(1):547-54.
PMID: 25333206
Sprouty2 is known for its tumor-suppressing effect in various human malignant diseases. In head and neck squamous cell carcinoma (HNSCC), the role of sprouty2 in tumorigenesis and clinical implication remains...
2.
Su B, Shen W, Chang S, Feng L, Wu C, Feng Y
Oncol Lett
. 2012 Jul;
3(6):1280-1282.
PMID: 22783433
The oral tyrosine kinase inhibitors of epidermal growth factor, erlotinib and gefitinib, are active in the treatment of non-small cell lung cancer (NSCLC). However, a number of skin manifestations have...
3.
Feng Y, Wu C, Shiau A, Lee J, Chang J, Lu P, et al.
Int J Mol Med
. 2012 Feb;
29(5):920-6.
PMID: 22322462
Sprouty2 (Spry2) was identified recently as a tumor suppressor gene in cancer cells which inhibits the activation of receptor tyrosine kinases (RTKs). The present study explored the effect of Spry2...